agilon health (AGL) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

agilon health

NYSE•Healthcare•Medical Care Facilities

$89.16-0.01(<0.01%)After hours

Market Cap

$1.49B

P/S

0.3x

P/B

6.5x

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.

How this company scores

AverageMetricSide Score: 53/100

Strongest: Balance Sheet & Red Flags (22/25); weakest: Cash & Earnings Quality (4/25).

Profitability15/25

Growth12/25

Balance Sheet & Red Flags22/25

Cash & Earnings Quality4/25

Strengths

Low leverageProfit converts from growthNet cash positionImproving margins

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/S · 0.3x5y range 0.0x – 5.9x

Currently below its 19-quarter median.

P/B · 6.5x5y range 0.7x – 9.9x

Currently near its 20-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

Free cash flow has been negative in 6 of the last 8 quarters — earnings are not translating to cash.

Price & Volume

Market Cap $1.49B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $5.92B
Q. Revenue: $1.49B
TTM EBITDA: $-281.28M
TTM Op. Income: $-309.33M
Q. Op. Income: $11.77M
TTM Net Income: $-232.22M
Q. Net Income: $17.96M
EPS: $1.07
Shares Out.: $16.70M

$5.92B in TTM revenue grew 0.3% YoY, reaching $1.49B last quarter. TTM EBITDA of $-281.28M and TTM operating income of $-309.33M show growth is flowing through to the bottom line. However, net income is negative at $232.22M — growth is not yet reaching the bottom line. Over the past year, TTM revenue is up 0% — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 1.2%
Op. Margin: 0.8%
Net Margin: 1.2%

Op. margin of 0.8% is up 9.1% YoY — cost efficiency is improving. Net margin at 1.2% Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 0.3x
P/B Ratio: 6.5x

P/S of 0.3x and P/B of 6.5x. P/S is low relative to typical market levels.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $1.59B
Cash: $107.18M
Long-Term Debt: $15.38M
Book Value: $227.53M
D/E Ratio: 0.1
Debt/EBITDA: 0.8

With $1.59B in assets and $15.38M in long-term debt, D/E is 0.1and book value is $227.53M — a conservative capital structure with a cushion to weather downturns. Across the last 5 quarters, debt/equity has fallen for 2 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-57.30M
TTM Free Cash Flow: $-84.95M
FCF Margin: -1.4%
FCF / Net Income: 0.4

TTM FCF of $-84.95M on $-57.30M in operating cash flow. The FCF / Net Income ratio of 0.4x means cash covers only part of net income — earnings quality needs attention. Over the past year, free cash flow is down 18% — a weakening trend.